Categories: All postsAnalysts

Medical Facilities Corp. gets price target raise at Canaccord Genuity

The announcement of a new facility has Canaccord Genuity analyst Neil Maruoka feeling bullish about Medical Facilities Corp. (Medical Facilities Corp. Stock Quote, Chart, News: TSX:DR).

This morning, Arkansas Surgical Hospital, a subsidiary of Medical Facilities Corp. announced it had entered into a joint venture with Ambulatory Innovation Associates to establish an urgent care centre in Little Rock, Arkansas.

“Providing the residents of Little Rock and the surrounding area with a broad range of urgent ambulatory care procedures through this new centre reflects our continuing commitment to the highest levels of patient care,” said Arkansas Surgical Hospital CEO Carrie Helm. “Patients at this new facility will receive the same quality of care and attention to detail as the five-star service they receive at ASH.”

Maruoka says that though he expects this development won’t immediately make a big difference to the company’s balance sheet, it is a positive sign.

“The new facility will provide laboratory, imaging, and diagnostic services to patients at MFC’s Arkansas Surgical Hospital (ASH); further, we expect this urgent care will have similar brand recognition to the high-quality image of ASH,” the analyst says. “While the new urgent care centre is likely to have a modest incremental financial impact in the near term, more importantly we believe this initiative is a strong indication that MFC continues to advance its strategy despite the recent and abrupt departure of CEO Britt Reynolds.”

In a research update to clients today, Maruoka maintained his “Buy” rating, but raised his one-year price target on Medical Facilities Corp. from $14.50 to $16.00, implying a return of 16.2 per cent at the time of publication.

Maruoka believes Medical Facilities Corp will generate EBITDA of $105.0-million on sales of $383.5-million in fiscal 2017. He expects those numbers will improve to EBITDA of $111.1-million on a topline of $377.6-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: dr
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

2 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

2 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

2 days ago

Rogers is an undervalued stock, RBC says

With the integration of Shaw Communications underway, RBC analyst Drew McReynolds says Rogers Communications (Rogers Communications Stock Quote, Chart, News,… [Read More]

3 days ago

Tornado Global Hydrovacs is still a double, Beacon says

Following fourth quarter results he describes as "stronger than expected", Beacon Securities analyst Russell Stanley has raised his price target… [Read More]

3 days ago

Sell your Molson Coors stock, Citi says

Ahead if its first quarter results, Citi analyst Filippo Falorni says there is not much to like about Molson Coors… [Read More]

4 days ago